Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

In this review, we will explore the various aspects of GetSimpli Oral Tirzepatide, including its ingredients, benefits, usage, and pricing. By the end, you will have a comprehensive understanding ...

When the FDA took tirzepatide off of its shortage list in December, the stock price of Hims & Hers fell amid concerns about the telehealth company's GLP-1 business. In January, Citi downgraded its ...

Let’s understand the company’s strengths and weaknesses to better analyze how to play the stock after the price drop. Tirzepatide is a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA).